These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16203365)

  • 1. Pharmacological properties of ketamine.
    White JM; Ryan CF
    Drug Alcohol Rev; 1996 Jun; 15(2):145-55. PubMed ID: 16203365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ketamine: clinically useful--pharmacologically interesting].
    Maurset A; Oye I
    Nord Med; 1990; 105(6-7):182-3, 186. PubMed ID: 2164188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketamine associated psychedelic effects and dependence.
    Lim DK
    Singapore Med J; 2003 Jan; 44(1):31-4. PubMed ID: 12762561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanisms of action of ketamine].
    Adams HA
    Anaesthesiol Reanim; 1998; 23(3):60-3. PubMed ID: 9707750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers.
    Gouzoulis-Mayfrank E; Heekeren K; Neukirch A; Stoll M; Stock C; Obradovic M; Kovar KA
    Pharmacopsychiatry; 2005 Nov; 38(6):301-11. PubMed ID: 16342002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low dose ketamine: a therapeutic and research tool to explore N-methyl-D-aspartate (NMDA) receptor-mediated plasticity in pain pathways.
    Chizh BA
    J Psychopharmacol; 2007 May; 21(3):259-71. PubMed ID: 17591654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anxiolytic- and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models.
    Engin E; Treit D; Dickson CT
    Neuroscience; 2009 Jun; 161(2):359-69. PubMed ID: 19321151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketamine.
    Sinner B; Graf BM
    Handb Exp Pharmacol; 2008; (182):313-33. PubMed ID: 18175098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Journey through the K-hole: phenomenological aspects of ketamine use.
    Muetzelfeldt L; Kamboj SK; Rees H; Taylor J; Morgan CJ; Curran HV
    Drug Alcohol Depend; 2008 Jun; 95(3):219-29. PubMed ID: 18355990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive and subjective acute dose effects of intramuscular ketamine in healthy adults.
    Lofwall MR; Griffiths RR; Mintzer MZ
    Exp Clin Psychopharmacol; 2006 Nov; 14(4):439-49. PubMed ID: 17115871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of ketamine in pain management.
    Visser E; Schug SA
    Biomed Pharmacother; 2006 Aug; 60(7):341-8. PubMed ID: 16854557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal NMDA receptor antagonist treatments have no effects on prepulse inhibition of postnatal day 25 Sprague-Dawley rats.
    Boctor SY; Ferguson SA
    Neurotoxicology; 2009 Jan; 30(1):151-4. PubMed ID: 19038286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies with ketamine and alfentanil following Freund's complete adjuvant-induced inflammation in rats.
    Edwards SR; Mather LE; Smith MT
    Clin Exp Pharmacol Physiol; 2007; 34(5-6):414-20. PubMed ID: 17439409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative vigilance in patients with total intravenous anaesthesia with ketamine/propofol.
    Felfernig M; Andel D; Weintraud M; Connor D; Andel H; Blaicher AM
    J R Nav Med Serv; 2006; 92(2):64-8. PubMed ID: 16892754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of NMDA receptor antagonists on visceromotor reflexes and on intestinal motility, in vivo.
    Shafton AD; Bogeski G; Kitchener PD; Sanger GJ; Furness JB; Shimizu Y
    Neurogastroenterol Motil; 2007 Jul; 19(7):617-24. PubMed ID: 17539896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perceptual organization in ketamine users: preliminary evidence of deficits on night of drug use but not 3 days later.
    Uhlhaas PJ; Millard I; Muetzelfeldt L; Curran HV; Morgan CJ
    J Psychopharmacol; 2007 May; 21(3):347-52. PubMed ID: 17591661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecal antinociceptive interaction between the NMDA antagonist ketamine and the opioids, morphine and biphalin.
    Kosson D; Klinowiecka A; Kosson P; Bonney I; Carr DB; Mayzner-Zawadzka E; Lipkowski AW
    Eur J Pain; 2008 Jul; 12(5):611-6. PubMed ID: 18068383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical toxicology of ketamine.
    Schep LJ; Slaughter RJ; Watts M; Mackenzie E; Gee P
    Clin Toxicol (Phila); 2023 Jun; 61(6):415-428. PubMed ID: 37267048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological modelling of dissociation and psychosis: an evaluation of the Clinician Administered Dissociative States Scale and Psychotomimetic States Inventory during nitrous oxide ('laughing gas')-induced anomalous states.
    Piazza GG; Iskandar G; Hennessy V; Zhao H; Walsh K; McDonnell J; Terhune DB; Das RK; Kamboj SK
    Psychopharmacology (Berl); 2022 Jul; 239(7):2317-2329. PubMed ID: 35348804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ketamine for paediatric anaesthesia: useful, fool or...?].
    De Kock M
    Ann Fr Anesth Reanim; 2007 Jun; 26(6):524-8. PubMed ID: 17524599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.